Cargando…
Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial
BACKGROUND: Cardiac disease is the most common cause of morbidity and mortality in the United Kingdom. Even minor changes in thyroid hormone concentration may impact adversely on the cardiovascular system. Subclinical hypothyroidism (SCH) after admission for an acute cardiac problem has been associa...
Autores principales: | Jabbar, Avais, Ingoe, Lorna, Pearce, Simon, Zaman, Azfar, Razvi, Salman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379597/ https://www.ncbi.nlm.nih.gov/pubmed/25872532 http://dx.doi.org/10.1186/s13063-015-0621-5 |
Ejemplares similares
-
Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study
por: Jabbar, A., et al.
Publicado: (2020) -
Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction
por: Razvi, Salman, et al.
Publicado: (2022) -
Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality
por: Andersen, Mette Nygaard, et al.
Publicado: (2015) -
Lipid Profile of Patients with Acute Myocardial Infarction (AMI)
por: Kumar, Naresh, et al.
Publicado: (2019) -
Acute Myocardial Infarction (AMI) Treated with Snake Antivenom
por: Salem, Waleed, et al.
Publicado: (2021)